There is a little known company that is changing warfare

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

David Shaw Biography and Net Worth

Major Shareholder of Schrödinger

David Shaw is the founder of D. E. Shaw & Co., a hedge fund described by Fortune as "the most intriguing and mysterious force on Wall Street." Additionally, he is the chief scientist for D.E. Shaw Research, which is engaged in scientific research and technological development in the field of computational biochemistry.

Shaw worked as a vice president for Morgan Stanley, as well as serving on Columbia University’s computer science faculty until 1986, when he set out on his own to pursue computational finance. He founded D.E. Shaw & Co. in 1988 and was dubbed “King Quant” by Fortune in 1996 because of the firm's pioneering role in high-speed quantitative trading.

Shaw initiated his work on computational biochemistry, specifically molecular dynamics simulations of proteins, in 2001, and he began building his scientific team at D. E. Shaw Research in 2002. A few years later in 2005, he reinitiated his affiliation with Columbia. He currently serves as a senior research fellow and an adjunct professor of biochemistry and molecular biophysics.

In 1994, Shaw was appointed to the President’s Council of Advisors on Science and Technology by President Clinton, and in 2009, he joined the council again under President Obama. Additionally, in 2012, he was elected to the National Academy of Engineering. He is a fellow of the American Academy of Arts and Sciences and a recipient of the ACM Gordon Bell Prize.

Shaw holds a bachelor’s degree from the University of California, San Diego and a Ph.D. from Stanford University.

What is David E. Shaw's net worth?: The estimated net worth of David E. Shaw is at least $166.52 million as of November 23rd, 2020. Mr. Shaw owns 8,981,664 shares of Schrödinger stock worth more than $166,520,051 as of November 17th. This net worth approximation does not reflect any other investments that Mr. Shaw may own. Learn More about David E. Shaw's net worth.
How do I contact David E. Shaw?: The corporate mailing address for Mr. Shaw and other Schrödinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrödinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on David E. Shaw's contact information.
Has David E. Shaw been buying or selling shares of Schrödinger?: David E. Shaw has not been actively trading shares of Schrödinger in the last ninety days. Most recently, David E. Shaw sold 63,061 shares of the business's stock in a transaction on Monday, July 19th. The shares were sold at an average price of $68.07, for a transaction totalling $4,292,562.27. Learn More on David E. Shaw's trading history.
Who are Schrödinger's active insiders?: Schrödinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrödinger's active insiders.
Are insiders buying or selling shares of Schrödinger?: During the last twelve months, insiders at the sold shares 5 times. They sold a total of 5,182 shares worth more than $129,616.27. The most recent insider tranaction occured on October, 15th when insider Margaret Dugan sold 1,531 shares worth more than $27,221.18. Insiders at Schrödinger own 8.6% of the company. Learn More about insider trades at Schrödinger.
Information on this page was last updated on 10/15/2024.

David E. Shaw Insider Trading History at Schrödinger

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/19/2021	Sell	63,061	$68.07	$4,292,562.27
7/16/2021	Sell	29,000	$67.05	$1,944,450.00
7/14/2021	Sell	34,051	$68.05	$2,317,170.55
7/12/2021	Sell	20,930	$74.33	$1,555,726.90
7/8/2021	Sell	48,410	$74.40	$3,601,704.00
7/6/2021	Sell	25,230	$75.29	$1,899,566.70
7/1/2021	Sell	41,575	$76.22	$3,168,846.50
6/25/2021	Sell	220,394	$77.99	$17,188,528.06
6/23/2021	Sell	53,946	$77.00	$4,153,842.00
6/21/2021	Sell	60,449	$74.86	$4,525,212.14
6/18/2021	Sell	52,784	$74.47	$3,930,824.48
6/16/2021	Sell	37,195	$74.36	$2,765,820.20
6/14/2021	Sell	43,463	$77.51	$3,368,817.13
5/26/2021	Sell	980	$68.93	$67,551.40
5/24/2021	Sell	27,594	$65.47	$1,806,579.18
5/20/2021	Sell	25,000	$64.23	$1,605,750.00
5/18/2021	Sell	28,402	$63.96	$1,816,591.92
5/14/2021	Sell	25,000	$60.31	$1,507,750.00
5/12/2021	Sell	25,000	$60.33	$1,508,250.00
5/6/2021	Sell	30,000	$66.96	$2,008,800.00
5/4/2021	Sell	30,000	$69.79	$2,093,700.00
4/29/2021	Sell	101,525	$76.58	$7,774,784.50
4/21/2021	Sell	30,000	$71.71	$2,151,300.00
4/19/2021	Sell	30,000	$74.13	$2,223,900.00
4/15/2021	Sell	45,000	$78.27	$3,522,150.00
4/13/2021	Sell	40,400	$74.89	$3,025,556.00
4/9/2021	Sell	35,000	$74.00	$2,590,000.00
4/7/2021	Sell	35,600	$76.00	$2,705,600.00
4/1/2021	Sell	184,043	$76.12	$14,009,353.16
3/24/2021	Sell	50,000	$68.68	$3,434,000.00
3/22/2021	Sell	50,000	$81.36	$4,068,000.00
3/18/2021	Sell	30,000	$77.71	$2,331,300.00
3/16/2021	Sell	41,173	$80.64	$3,320,190.72
3/11/2021	Sell	51,367	$79.03	$4,059,534.01
3/9/2021	Sell	33,480	$69.43	$2,324,516.40
3/5/2021	Sell	30,000	$68.03	$2,040,900.00
3/3/2021	Sell	40,000	$101.76	$4,070,400.00
2/24/2021	Sell	116,443	$112.07	$13,049,767.01
2/22/2021	Sell	276,250	$113.78	$31,431,725.00
2/19/2021	Sell	72,367	$104.83	$7,586,232.61
2/17/2021	Sell	45,000	$104.82	$4,716,900.00
12/10/2020	Sell	127,515	$66.94	$8,535,854.10
12/8/2020	Sell	90,748	$66.33	$6,019,314.84
12/4/2020	Sell	207,239	$65.50	$13,574,154.50
12/2/2020	Sell	62,607	$65.74	$4,115,784.18
11/25/2020	Sell	100,364	$64.35	$6,458,423.40
11/23/2020	Sell	567,017	$67.63	$38,347,359.71	8,981,664
11/19/2020	Sell	120,051	$59.02	$7,085,410.02
11/17/2020	Sell	167,202	$59.80	$9,998,679.60
11/5/2020	Sell	348,747	$53.70	$18,727,713.90
11/3/2020	Sell	110,000	$48.80	$5,368,000.00
10/30/2020	Sell	122,000	$48.55	$5,923,100.00
10/28/2020	Sell	124,711	$55.33	$6,900,259.63
10/21/2020	Sell	474,453	$56.63	$26,868,273.39
10/19/2020	Sell	187,446	$57.42	$10,763,149.32
10/15/2020	Sell	705,304	$58.45	$41,225,018.80
10/13/2020	Sell	244,698	$59.32	$14,515,485.36
10/9/2020	Sell	919,793	$55.10	$50,680,594.30
10/7/2020	Sell	216,061	$53.86	$11,637,045.46
9/30/2020	Sell	178,366	$48.41	$8,634,698.06
9/28/2020	Sell	154,840	$48.38	$7,491,159.20
9/24/2020	Sell	150,000	$47.58	$7,137,000.00
9/22/2020	Sell	145,525	$51.40	$7,479,985.00
9/17/2020	Sell	159,923	$51.67	$8,263,221.41
9/15/2020	Sell	205,965	$53.97	$11,115,931.05

David E. Shaw Buying and Selling Activity at Schrödinger

Schrödinger Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Today's Range

Now: $18.54

$18.46

$20.46

50 Day Range

MA: $18.72

$16.98

$22.25

2 Week Range

Now: $18.54

$16.67

$38.00

Volume

1,221,118 shs

Average Volume

876,651 shs

Market Capitalization

$1.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5